{"owner":"TCGA","longTitle":"TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) reverse phase protein array","cohort":"TCGA Cervical Cancer (CESC)","url":"https://tcga-data.nci.nih.gov/tcgafiles/ftp_auth/distro_ftpusers/anonymous/tumor/cesc/cgcc/mdanderson.org/mda_rppa_core/protein_exp/","dataSubType":"protein expression RPPA","security":"public","label":"RPPA","tags":["cancer"],"path":"data/public/TCGA/CESC/RPPA","anatomical_origin":["Cervix"],"name":"TCGA.CESC.sampleMap/RPPA","dataproducer":"MD Anderson Cancer Center TCGA proteome characterization center","wrangling_procedure":"Level_3 Data (file names: *.protein_expression.*) download from TCGA DCC, and processed at UCSC into Xena repository","sample_type":["tumor"],"redistribution":true,"domain":"TCGA","type":"genomicMatrix","wrangler":"Xena TCGAscript RPPA processed on 2017-09-08","version":"2017-09-08","unit":"normalized RPPA value","primary_disease":"cervical & endocervical cancer","platform":"M.D. Anderson Reverse Phase Protein Array Core platform","colnormalization":true,"description":"TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) protein expression by reverse phase protein array (RPPA).<br><br> The data was generated and processed at the MD Anderson Cancer Center TCGA proteome characterization center RPPA core. Level 3 interpreted level data was downloaded from TCGA data coordination center.<br><br>Data normalization from the MDACC RPPA core: <a href=\"http://bioinformatics.mdanderson.org/main/TCPA:Overview\" target=\"_blank\"><u>under section How are the RPPA data processed</u></a>.<br>"}

TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) reverse phase protein array

TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) segmented copy number

TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) exon expression by RNAseq (polyA+ IlluminaHiSeq)

{"cgdataversion":1,"owner":"TCGA","longTitle":"TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) PARADIGM inference activity (RNAseq)","cohort":"TCGA Cervical Cancer (CESC)","url":"http://gdac.broadinstitute.org/runs/analyses__2016_01_28/data/CESC/20160128/","probeMap":"paradigmPathwayV1.probeMap","dataSubType":"PARADIGM pathway activity","security":"public","label":"expression","tags":["cancer"],"path":"data/public/TCGA/CESC/Pathway_Paradigm_RNASeq","anatomical_origin":["Cervix"],"name":"TCGA.CESC.sampleMap/Pathway_Paradigm_RNASeq","dataproducer":"TCGA FIREHOSE pipeline","wrangling_procedure":"FIREHOSE data download from TCGA DCC, processed at UCSC into cgData repository","sample_type":["tumor"],"redistribution":true,"domain":"TCGA","groupTitle":"TCGA cervical & endocervical cancer","type":"genomicMatrix","wrangler":"cgData TCGAscript Pathway_Paradigm processed on 2017-09-08","version":"2017-09-08","primary_disease":"cervical & endocervical cancer","description":"Broad FireHose automated run results of TCGA cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) gene activity level inferred using the PARADIGM method on RNAseq data alone.<br><br>PARADIGM (PMID 20529912) is pathway analysis method to infer tumor sample-specific genetic activities by incorporating curated pathway interactions as well as integrating diverse types of genomic data. The pathways used in this analysis are from <a href=\"http://pid.nci.nih.gov/\" target=\"_blank\"><u>NCI pathway interaction database</u></a>.<br><br>"}